sivelestat has been researched along with Injury, Myocardial Reperfusion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bessho, R; Fujii, M | 1 |
Angelos, MG; Aune, SE; Khan, M; Kuppusamy, ML; Kuppusamy, P; Yeh, ST | 1 |
Bessho, R; Fujii, M; Kambe, M; Ochi, M; Shimizu, K | 1 |
3 other study(ies) available for sivelestat and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Neutrophil Elastase Inhibitor Sivelestat Attenuates Myocardial Injury after Cardioplegic Arrest in Rat Hearts.
Topics: Animals; Disease Models, Animal; Glycine; Heart Arrest, Induced; Isolated Heart Preparation; Leukocyte Elastase; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Serine Proteinase Inhibitors; Sulfonamides; Troponin T; Ventricular Function, Left; Ventricular Pressure | 2020 |
Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion.
Topics: Animals; Aorta; Cardiotonic Agents; Cattle; Coronary Circulation; Creatine Kinase; Electron Spin Resonance Spectroscopy; Endothelial Cells; Glycine; Heart Ventricles; In Vitro Techniques; Male; Models, Cardiovascular; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfonamides; Superoxides; Vasoconstriction; Ventricular Function, Left | 2013 |
Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Topics: Acetylcholine; Animals; Cardiotonic Agents; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycine; In Vitro Techniques; Leukocyte Elastase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Sulfonamides; Troponin T; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2009 |